Past ARDS Speakers
“The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.”
David Parke, II
Records per page:
2015 43rd Annual Meeting
Lihteh Wu, MDAn Update on Macular Telangiectasia Type 2
Lihteh Wu, MDBevacizumab as an Adjuvant in Diabetic Vitrectomies
Panel DiscussionAdvances in Retinal Imaging and Pharmacotherapy
Panel DiscussionComplex Surgical Management of Retinal Disease
Panel DiscussionFuture Directions in Vitreoretinal Patient Care and ACCESS
2014 42nd Annual Meeting
Thomas A. Albini, MDSustained Release Steroids for the Treatment of Noninfectious Uveitis
Maria H. Berrocal, MDGiant Retinal Tear Repair in the MIVS Era
Maria H. Berrocal, MDMIVS Vitreoretinal Techniques for Diabetic Detachments
R.V. Paul Chan, MDManagement of Pediatric Vitreous Hemorrhage and Trauma
Donald J. D'Amico, MDCurrent Perspectives on Retinotomies and Retinectomies
Harry W. Flynn, Jr., MDCompounding Pharmacies and Endophthalmitis
Harry W. Flynn, Jr., MDManagement Options for Vitreomacular Adhesion
Thomas R. Friberg, MDAn Extended Release Platform for Ophthalmic Drug Delivery
Thomas R. Friberg, MDThe Peripheral Retina and its Implications for Age-Related Macular Degeneration
Julia A. Haller, MDNothing in Vein: The Evolution of Management of Retinal Vein Occlusions
Szilárd Kiss, MDLatest Observations on Wide-Field Imaging of Retinal Diseases
David W. Parke, II, MDThe Law of Unintended Consequences in Health Care Reform
Carl D. Regillo, MDAnti-VEGF Maintenance Therapy for Neovascular AMD
Srinivas R. Sadda, MDFuture Optical Coherence Tomography (OCT) Imaging
Srinivas R. Sadda, MDLocal Risk Factors for Development of Geographic Atrophy: New Insights into AMD Pathogenesis
Ramin Tadayoni, MD, PhDHigh Myopia: What We Peel and What We Should Peel
Ramin Tadayoni, MD, PhDIs Fluorescein Angiography Still the Sole Gold Standard for the Diagnosis of Neovascular AMD?
2013 41st Annual Meeting
David M. Brown, MDCan Widefield FFA-guided PRP Decrease Treatment Burden in Vascular Diseases?
David M. Brown, MDIs There a Correlation Between Changes in OCT and Visual Acuity in the Management of Wet ARMD?
Philip J. Ferrone, MDAdvanced Imaging and Intravitreal Therapy in the Pediatric Patient
PREV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 NEXT